Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Apr;117(7):1586–1592. doi: 10.1111/j.1476-5381.1996.tb15325.x

Inhibition of the contraction of the ductus arteriosus to oxygen by 1-aminobenzotriazole, a mechanism-based inactivator of cytochrome P450.

F Coceani 1, L Kelsey 1, E Seidlitz 1, K Korzekwa 1
PMCID: PMC1909445  PMID: 8730758

Abstract

1. We have proposed that contractile tension of the ductus arteriosus is sustained by a cytochrome P450-linked mechanism acting as a limiting step in the synthesis of endothelin-1 (ET-1). In the present study, we have used the isolated ductus from near-term foetal lambs and guinea-pigs to investigate the effect on both muscle tone and ET-1 formation of 1-aminobenzotriazole (ABT), a suicide substrate for mono-oxygenase reactions. 2. ABT relaxed the lamb ductus at rest (2.5% O2) and during the oxygen contraction (15 to 95% O2). The effect was seen at 40 microM, and at 0.8 mM active tone was almost completely abolished. ABT (1 mM) also reversed the oxygen contraction in the guinea-pig ductus. 3. In the lamb ductus, the ABT response was not affected by removal of the endothelium or by treatment with 2.8 microM indomethacin (at 2.5% O2) and the ensuing contraction. 4. At both low and high concentration, ABT relaxed marginally, or not at all, the potassium-contracted (55 mM) ductus from either species. 5. ET-1 release from either the intact or endothelium-denuded lamb ductus tended to decrease in the presence of ABT (1 mM), whilst during the same treatment cyclic GMP content of the tissue remained unchanged. 6. We conclude that ABT relaxation is due to suppression of a contractile mechanism and not to activation of prostaglandin- and NO-mediated relaxing mechanisms. This contractile mechanism has a cytochrome P450-based mono-oxygenase reaction as a key component.

Full text

PDF
1586

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodach E., Coceani F., Dumbrille A., Okpako D. T., Olley P. M. The response of the isolated ductus arteriosus to transmural stimulation and drugs. Br J Pharmacol. 1980;71(2):419–427. doi: 10.1111/j.1476-5381.1980.tb10954.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buters J. T., Korzekwa K. R., Kunze K. L., Omata Y., Hardwick J. P., Gonzalez F. J. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metab Dispos. 1994 Sep-Oct;22(5):688–692. [PubMed] [Google Scholar]
  3. Clyman R. I., Ballard P. L., Sniderman S., Ballard R. A., Roth R., Heymann M. A., Granberg J. P. Prenatal administration of betamethasone for prevention of patient ductus arteriosus. J Pediatr. 1981 Jan;98(1):123–126. doi: 10.1016/s0022-3476(81)80557-4. [DOI] [PubMed] [Google Scholar]
  4. Clyman R. I., Mauray F., Roman C., Heymann M. A., Ballard P. L., Rudolph A. M., Payne B. Effects of antenatal glucocorticoid administration on ductus arteriosus of preterm lambs. Am J Physiol. 1981 Sep;241(3):H415–H420. doi: 10.1152/ajpheart.1981.241.3.H415. [DOI] [PubMed] [Google Scholar]
  5. Clyman R. I., Mauray F., Roman C., Rudolph A. M., Heymann M. A. Glucocorticoids alter the sensitivity of the lamb ductus arteriosus to prostaglandin E2. J Pediatr. 1981 Jan;98(1):126–128. doi: 10.1016/s0022-3476(81)80558-6. [DOI] [PubMed] [Google Scholar]
  6. Coceani F., Breen C. A., Lees J. G., Falck J. R., Olley P. M. Further evidence implicating a cytochrome P-450-mediated reaction in the contractile tension of the lamb ductus arteriosus. Circ Res. 1988 Mar;62(3):471–477. doi: 10.1161/01.res.62.3.471. [DOI] [PubMed] [Google Scholar]
  7. Coceani F. Control of the ductus arteriosus--a new function for cytochrome P450, endothelin and nitric oxide. Biochem Pharmacol. 1994 Oct 7;48(7):1315–1318. doi: 10.1016/0006-2952(94)90552-5. [DOI] [PubMed] [Google Scholar]
  8. Coceani F., Hamilton N. C., Labuc J., Olley P. M. Cytochrome P 450-linked monooxygenase: involvement in the lamb ductus arteriosus. Am J Physiol. 1984 Apr;246(4 Pt 2):H640–H643. doi: 10.1152/ajpheart.1984.246.4.H640. [DOI] [PubMed] [Google Scholar]
  9. Coceani F., Huhtanen D., Hamilton N. C., Bishai I., Olley P. M. Involvement of intramural prostaglandin E2 in prenatal patency of the lamb ductus arteriosus. Can J Physiol Pharmacol. 1986 Jun;64(6):737–744. doi: 10.1139/y86-124. [DOI] [PubMed] [Google Scholar]
  10. Coceani F., Kelsey L., Ackerley C., Rabinovitch M., Gelboin H. Cytochrome P450 during ontogenic development: occurrence in the ductus arteriosus and other tissues. Can J Physiol Pharmacol. 1994 Mar;72(3):217–226. doi: 10.1139/y94-034. [DOI] [PubMed] [Google Scholar]
  11. Coceani F., Kelsey L. Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can J Physiol Pharmacol. 1991 Feb;69(2):218–221. doi: 10.1139/y91-033. [DOI] [PubMed] [Google Scholar]
  12. Coceani F., Kelsey L., Seidlitz E. Evidence for an effector role of endothelin in closure of the ductus arteriosus at birth. Can J Physiol Pharmacol. 1992 Jul;70(7):1061–1064. doi: 10.1139/y92-146. [DOI] [PubMed] [Google Scholar]
  13. Coceani F., Olley P. M., Bishai I., Bodach E., White E. P. Significance of the prostaglandin system to the control of muscle tone of the ductus arteriosus. Adv Prostaglandin Thromboxane Res. 1978;4:325–333. [PubMed] [Google Scholar]
  14. Crespi C. L. Expression of cytochrome P450 cDNAs in human B lymphoblastoid cells: applications to toxicology and metabolite analysis. Methods Enzymol. 1991;206:123–129. doi: 10.1016/0076-6879(91)06084-g. [DOI] [PubMed] [Google Scholar]
  15. Fay F. S. Guinea pig ductus arteriosus. I. Cellular and metabolic basis for oxygen sensitivity. Am J Physiol. 1971 Aug;221(2):470–479. doi: 10.1152/ajplegacy.1971.221.2.470. [DOI] [PubMed] [Google Scholar]
  16. Freeman B. A., Crapo J. D. Biology of disease: free radicals and tissue injury. Lab Invest. 1982 Nov;47(5):412–426. [PubMed] [Google Scholar]
  17. Gonzalez F. J., Aoyama T., Gelboin H. V. Expression of mammalian cytochrome P450 using vaccinia virus. Methods Enzymol. 1991;206:85–92. doi: 10.1016/0076-6879(91)06079-i. [DOI] [PubMed] [Google Scholar]
  18. Grogan J., Shou M., Zhou D., Chen S., Korzekwa K. R. Use of aromatase (CYP19) metabolite ratios to characterize electron transfer from NADPH-cytochrome P450 reductase. Biochemistry. 1993 Nov 16;32(45):12007–12012. doi: 10.1021/bi00096a010. [DOI] [PubMed] [Google Scholar]
  19. Halpert J. R., Guengerich F. P., Bend J. R., Correia M. A. Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol. 1994 Apr;125(2):163–175. doi: 10.1006/taap.1994.1061. [DOI] [PubMed] [Google Scholar]
  20. Hughes D., Murphy J. F., Dyas J., Robinson J. A., Riad-Fahmy D., Hughes I. A. Blood spot glucocorticoid concentrations in ill preterm infants. Arch Dis Child. 1987 Oct;62(10):1014–1018. doi: 10.1136/adc.62.10.1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ikeda M., Rubinstein E. H., Sonnenschein R. R. Interaction of three factors in the closure of the ductus arteriosus. Proc Soc Exp Biol Med. 1973 Jun;143(2):354–359. doi: 10.3181/00379727-143-37319. [DOI] [PubMed] [Google Scholar]
  22. Kim N., Vardi Y., Padma-Nathan H., Daley J., Goldstein I., Saenz de Tejada I. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest. 1993 Feb;91(2):437–442. doi: 10.1172/JCI116220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Knickle L. C., Bend J. R. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids. Mol Pharmacol. 1994 Jun;45(6):1273–1280. [PubMed] [Google Scholar]
  24. Knickle L. C., Bend J. R. Dose-dependent, mechanism-based inactivation of cytochrome P450 monooxygenases in vivo by 1-aminobenzotriazole in liver, lung, and kidney of untreated, phenobarbital-treated, and beta-naphthoflavone-treated guinea pigs. Can J Physiol Pharmacol. 1992 Dec;70(12):1610–1617. doi: 10.1139/y92-231. [DOI] [PubMed] [Google Scholar]
  25. Leemann T., Bonnabry P., Dayer P. Selective inhibition of major drug metabolizing cytochrome P450 isozymes in human liver microsomes by carbon monoxide. Life Sci. 1994;54(14):951–956. doi: 10.1016/0024-3205(94)00496-x. [DOI] [PubMed] [Google Scholar]
  26. Marks G. S., Brien J. F., Nakatsu K., McLaughlin B. E. Does carbon monoxide have a physiological function? Trends Pharmacol Sci. 1991 May;12(5):185–188. doi: 10.1016/0165-6147(91)90544-3. [DOI] [PubMed] [Google Scholar]
  27. Mathews J. M., Dostal L. A., Bend J. R. Inactivation of rabbit pulmonary cytochrome P-450 in microsomes and isolated perfused lungs by the suicide substrate 1-aminobenzotriazole. J Pharmacol Exp Ther. 1985 Oct;235(1):186–190. [PubMed] [Google Scholar]
  28. Needleman P., Turk J., Jakschik B. A., Morrison A. R., Lefkowith J. B. Arachidonic acid metabolism. Annu Rev Biochem. 1986;55:69–102. doi: 10.1146/annurev.bi.55.070186.000441. [DOI] [PubMed] [Google Scholar]
  29. Ortiz de Montellano P. R., Mathews J. M. Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Isolation of an NN-bridged benzyne-protoporphyrin IX adduct. Biochem J. 1981 Jun 1;195(3):761–764. doi: 10.1042/bj1950761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rettie A. E., Wienkers L. C., Gonzalez F. J., Trager W. F., Korzekwa K. R. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics. 1994 Feb;4(1):39–42. doi: 10.1097/00008571-199402000-00005. [DOI] [PubMed] [Google Scholar]
  31. SOMLYO A. V., SOMLYO A. P. VASOMOTOR FUNCTION OF SMOOTH MUSCLE IN THE MAIN PULMONARY ARTERY. Am J Physiol. 1964 Jun;206:1196–1200. doi: 10.1152/ajplegacy.1964.206.6.1196. [DOI] [PubMed] [Google Scholar]
  32. Smith G. C., McGrath J. C. Prostaglandin E2 and fetal oxygen tension synergistically inhibit response of isolated fetal rabbit ductus arteriosus to norepinephrine. J Cardiovasc Pharmacol. 1991 Jun;17(6):861–866. doi: 10.1097/00005344-199106000-00001. [DOI] [PubMed] [Google Scholar]
  33. Wrighton S. A., Stevens J. C. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol. 1992;22(1):1–21. doi: 10.3109/10408449209145319. [DOI] [PubMed] [Google Scholar]
  34. Yasuda N., Kasuya Y., Yamada G., Hama H., Masaki T., Goto K. Loss of contractile activity of endothelin-1 induced by electrical field stimulation-generated free radicals. Br J Pharmacol. 1994 Sep;113(1):21–28. doi: 10.1111/j.1476-5381.1994.tb16168.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zhou D. J., Pompon D., Chen S. A. Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening. Cancer Res. 1990 Nov 1;50(21):6949–6954. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES